Canada markets open in 8 hours 27 minutes

American Oncology Network, Inc. (AONC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.7100-0.0900 (-2.37%)
At close: 04:00PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    American Oncology Network Announces CFO Transition

    FORT MYERS, Fla., May 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today that Dave Gould will step down as Chief Financial Officer, effective May 17, 2024, to pursue other opportunities. AON has appointed David Afshar, a seasoned public company executive, to fulfill the responsibilities of interim Chief Financial Officer, effective May 20, 2024. AON has initiated a proces

  • GlobeNewswire

    American Oncology Network Announces First Quarter 2024 Earnings Release Date and Conference Call

    FORT MYERS, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial

  • GlobeNewswire

    American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada

    The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need. American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada From left to right: Shelly Glenn, AON's chief growth & relationship officer; Raja S. Mehdi, MD, medical oncologist at Hope Cancer Care of Nevada; Brian P. Mulherin, MD, medical oncologist at Hematology Oncology of Indiana; and Todd Schonh